Real-world efficacy and safety of efgartigimod in patients with autoimmune encephalitis: a single-center retrospective analysiss.

Song Z, Liang L, Zhang M, Zhang Y, Bu H, Zhang Y

Open source

DOI
10.3389/fimmu.2026.1963052
Published
2026
Container
Frontiers in immunology
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fimmu.2026.1963052,
  title = {Real-world efficacy and safety of efgartigimod in patients with autoimmune encephalitis: a single-center retrospective analysiss.},
  author = {Song Z and Liang L and Zhang M and Zhang Y and Bu H and Zhang Y},
  year = {2026},
  journal = {Frontiers in immunology},
  doi = {10.3389/fimmu.2026.1963052},
  url = {https://doi.org/10.3389/fimmu.2026.1963052}
}

RIS

TY  - JOUR
TI  - Real-world efficacy and safety of efgartigimod in patients with autoimmune encephalitis: a single-center retrospective analysiss.
AU  - Song Z
AU  - Liang L
AU  - Zhang M
AU  - Zhang Y
AU  - Bu H
AU  - Zhang Y
PY  - 2026
JO  - Frontiers in immunology
DO  - 10.3389/fimmu.2026.1963052
UR  - https://doi.org/10.3389/fimmu.2026.1963052
ER  - 

APA

Z, S., L, L., M, Z., Y, Z., H, B., & Y, Z. (2026). Real-world efficacy and safety of efgartigimod in patients with autoimmune encephalitis: a single-center retrospective analysiss.. Frontiers in immunology. https://doi.org/10.3389/fimmu.2026.1963052

Source records